日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Global cancer statistics for children: Two decades of change and projections to 2050

全球儿童癌症统计数据:二十年来的变化及至2050年的预测

Li, Wangzhong; Huang, Shanzhou; Chen, Qiyue; Wang, Ting; Lu, Guanming; Niu, Xing; Song, Qiong; Xu, Yilin; Mo, Ke; Cui, Chunhui; Zhang, Run; Du, Wei; He, Feiying; Shi, Lei; Lin, Yan; Wei, Qiu; Jiang, Li; Chen, Yongsheng; Song, Baiyang; Zhang, Huijuan; Fu, Zhenli; Liao, Wenjing; Sun, Jiancong; Guan, Wenhui; Zhuang, Weitao; Zhong, Nanshan; Zhou, Chengzhi; Liang, Wenhua; Kang, Min; He, Jianxing

Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study

奥莫替尼联合卡铂-培美曲塞对比奥莫替尼单药治疗EGFR和伴随肿瘤抑制基因的非小细胞肺癌(ACROSS2):一项开放标签、多中心、随机3期研究

Duan, Jian-Chun; Zhong, Jia; Sun, Bo-Yang; Zhao, Wen-Hua; Wu, Lin; Fei, Kai-Lun; Chu, Qian; Guo, Qi-Sen; Song, Qi-Bin; Yu, Yan; Zhu, Da-Xing; Liu, Xin-Yan; Zhao, Jun; Zhan, Zhi-Xiang; Li, Shi; Nie, Lei; Lin, Jie; Peng, Xiao-Dong; Zhong, Dian-Sheng; Zhou, Jin; Li, Li-Hua; Chen, Yun-Fang; Hu, Chen; Mok, Tony; Wang, Zhi-Jie; Wang, Jie

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS-1): A multicenter, randomized, double-blind, placebo-controlled phase 3 trial

一项多中心、随机、双盲、安慰剂对照的3期临床试验:在初诊晚期卵巢癌患者中,使用氟哌啶醇联合或不联合阿帕替尼作为维持治疗方案的疗效评价(FZOCUS-1):一项多中心、随机、双盲、安慰剂对照试验

Wu, Lingying; Wang, Jing; Li, Qingshui; Wang, Danbo; Zhang, Cuiying; Tang, Junying; Zhang, Guonan; Hao, Min; Yao, Desheng; Gao, Qinglei; Zhang, Youzhong; An, Ruifang; Yin, Rutie; Wang, Li; Xia, Bairong; Zhou, Qi; Yang, Hongying; Zhu, Jianqing; Jiang, Kui; Chen, Zhengzheng; Wu, Qiang; Duan, Wei; Huang, Yi; Zhang, Hui; Wei, Shuqing; Li, Guiling; Meng, Yuanguang; Wang, Ke; Yang, Xinfeng; Huang, Xianghua; Pan, Lingya; Yu, Jinjin; Lou, Ge; Zhang, Yu; Zhou, Huaijun; Guo, Xiaoqing; Yang, Hong; Cheng, Xiaodong; Li, Xiumin; Wang, Wuliang; Zhao, Hongqin; Li, Yunxia; Yang, Yingjie; Lin, An; Cheng, Wenjun; Chen, Lihong; Xie, Xiaoying; Di, Wen; Hu, Yuanjing; Chen, Mo; Wen, Hongwu; Cai, Liping; Wu, Xiaohua; Lin, Zhongqiu; Wang, Quanren; Yang, Xinfeng; Li, Ning

A multicenter randomized phase II trial of lenvatinib plus everolimus versus cabozantinib in patients with metastatic clear-cell RCC that progressed on PD-1 immune checkpoint inhibition (LenCabo)

一项多中心随机 II 期试验,比较乐伐替尼联合依维莫司与卡博替尼治疗 PD-1 免疫检查点抑制剂治疗后进展的转移性透明细胞肾细胞癌患者的疗效(LenCabo)

Hahn, A W; Chahoud, J; Skelton, W P; Yuan, Y; Zurita-Saavedra, A J; Kovitz, C; Alhalabi, O; Campbell, M T; Jonasch, E; Lin, J K; Desai, M; Santos, M J M N; Hwang, H; Corn, P G; Msaouel, P; Tannir, N M

In Cellulo Fabrication of Supramolecular Protein Assemblies

超分子蛋白组装体的细胞内制备

Yang, Hongru; Song, Chang Woo; Lu, Jiaxi; Lin, Dingchang

The consensus molecular subtypes of esophageal squamous cell carcinoma

食管鳞状细胞癌的共识分子亚型

Cui, Heyang; Zhu, Zhongxu; Xu, Enwei; Qi, Lin; Cheng, Yikun; Zhang, Yinghan; Zhang, Ling; Cheng, Matthew Yibo; Yang, Bin; Sun, Ruifang; Zhuang, Xiaofei; Xi, Yanfeng; Yan, Ting; Cheng, Caixia; Ding, Ning; Liu, Huijuan; Wang, Lu; Guo, Min; Guo, Dinghe; Zhang, Haoyu; Peng, Meilan; An, Zhekun; Weng, Yongjia; Wang, Fang; Liu, Meng; Xiong, Ruixin; Yin, Weihua; Song, Bin; Zhang, Weimin; Cheng, Xiaolong; Liu, Zhihua; Zhan, Qimin; Wang, Xin; Cui, Yongping

Glucocorticoids elevate clear cell renal cell carcinoma sensitivity to HIF-2α inhibitors by suppressing H4K12 lactylation

糖皮质激素通过抑制H4K12乳酸化作用,提高透明细胞肾细胞癌对HIF-2α抑制剂的敏感性。

Zhang, Kenan; He, Lin; Wang, Yizhou; Qin, Sen; Yu, Chunyu; Zheng, Enrun; Zhang, Zedan; Xu, Yawei; Chen, Xiaolin; Liu, Yanhua; Liu, Xiaoya; Guan, Sudun; Xia, Lu; Suo, Feiya; Pei, Fei; Du, Juan; Su, Yiran; Li, Yanze; Wu, Yu; Zhou, Xuehong; Zhou, Jingcheng; Cai, Lin; Tang, Xinjing; Zhang, Zheng; Shang, Yongfeng; Zhang, Qing; Gong, Kan; Sun, Luyang

Anti-PD-1 antibody penpulimab plus chemotherapy for recurrent or metastatic nasopharyngeal carcinoma: a randomized, double-blind phase 3 study

抗PD-1抗体penpulimab联合化疗治疗复发性或转移性鼻咽癌:一项随机、双盲3期研究

Huang, Shuang; Liu, Feng; Qu, Song; Chen, Lisha; Zhou, Ping; Qu, Shenhong; Ai, Xiaohong; Chen, Yong; Liu, Meilian; Wang, Rensheng; Chan, Kelvin Kw; Zhang, Peng; Hu, Chunhong; Wen, Jiyu; Zhang, Jian; Lin, Qin; Li, Xiaojiang; Gu, Kangsheng; Xiang, Li; Wang, Dongxia; Li, Jingao; Lin, Daren; Hu, Desheng; Ding, Jianwu; Wang, Siyang; Huang, Xiaoming; Wang, Lin; Jin, Feng; Pfister, David G; Mak, Milena Perez; Marchi, Pedro Rafael Martins de; Jiang, Yi; Yang, Haihua; Hu, Xiaoye; Liu, Tianrun; Wu, Dehua; Shreenivas, Aditya; Oliveira, Thiago Bueno de; Silva, Carlos Eduardo Baston; Alves, Gustavo Vasconcelos; Li, Xianming; Yao, Zhifang; Lu, Dongmei; Hu, Mingxiu; Wang, Zhongmin Maxwell; Li, Baiyong; Xia, Michelle; Chen, Xiaozhong; Hu, Chaosu; Xu, Tingting

Extraocular delivery of bioswitchable tri-miR-22-loaded tetrahedral DNA nanostructures for intraocular neovascular and neurodegenerative repair.

将载有生物可切换三 miR-22 的四面体 DNA 纳米结构进行眼外递送,用于眼内新生血管和神经退行性病变的修复。

Wang Qiong, Wang You, Chen Li, Huang Junyang, Cai Tao, Lin Yi, Liu Jingying, Liu Jinnan, Zhu Jiang, Li Rong, Luo Delun, Ding Xiaoyan

Implementation and evaluation of the Y-Check comprehensive adolescent health check-up intervention in Zimbabwe: a pre-post mixed-methods study

在津巴布韦实施和评估 Y-Check 青少年综合健康检查干预措施:一项前后混合方法研究

Doyle, Aoife M; Nzvere, Farirai; Manyau, Salome; Simms, Victoria; Li Lin, Ines; Kandiye, Faith R; Nyamayaro, Chipo Ashley; Takawira, Michaela; Chingono, Rudo M S; Tembo, Mandikudza; Manhibi, Ronald; Dauya, Ethel; Dziva Chikwari, Chido; Greco, Giulia; Bernays, Sarah; Baltag, Valentina; Maisiri, Hannah; Kasu, Tonderai; Nyamayaro, Wenceslas; Bandason, Tsitsi; Mackworth-Young, Constance R S; Banati, Prerna; Weiss, Helen A; Ross, David A; Ferrand, Rashida A